Regulatory Framework Overview
The Canadian regulatory framework
Canada's medical device regulatory framework is built on two primary instruments:
- Food and Drugs Act (FDA) — the enabling statute that gives Health Canada authority to regulate therapeutic products, including medical devices
- Medical Devices Regulations (SOR/98-282) — the principal regulations that set out the specific requirements for medical devices
Together, these instruments establish:
- The definition of a medical device
- The classification system (Class I–IV)
- Pre-market licensing requirements (Device Licence, MDEL)
- Safety and effectiveness requirements
- Labelling requirements
- Post-market obligations (mandatory problem reporting, recalls, surveillance)
Health Canada's Medical Devices Directorate
The Medical Devices Directorate (MDD) within Health Canada's Health Products and Food Branch is responsible for regulating medical devices in Canada. MDD's key functions include:
- Reviewing Device Licence applications
- Issuing and maintaining the Medical Devices Active Licence Listing (MDALL)
- Issuing and maintaining Medical Device Establishment Licences (MDELs)
- Conducting compliance inspections
- Managing mandatory problem reports
- Coordinating recalls
- Publishing guidance documents
Key regulatory instruments at a glance
| Instrument | Description | Link |
|---|---|---|
| Food and Drugs Act (FDA) | Enabling legislation | laws-lois.justice.gc.ca |
| Medical Devices Regulations (SOR/98-282) | Core device regulations | laws-lois.justice.gc.ca |
| Radiation Emitting Devices Act (REDA) | Radiation emitting devices | laws-lois.justice.gc.ca |
| Food and Drug Regulations | Drug-device combinations | laws-lois.justice.gc.ca |
The pre-market pathway
For most devices, the pre-market pathway follows these steps:
Device classification (Class I–IV)
↓
Class I: MDEL only
Class II–IV: Device Licence application → HC review → Licence issued → MDALL listing
↓
Post-market obligations begin
The post-market framework
After a device enters the Canadian market, ongoing obligations include:
- Mandatory Problem Reporting — reporting device-related incidents to Health Canada within defined timeframes
- Recalls — removing or correcting distributed devices when a safety issue arises
- Post-Market Surveillance — ongoing monitoring of device performance
- Device Licence amendments — notifying Health Canada of changes that affect safety, effectiveness, or labelling
- MDEL maintenance — keeping establishment licence information current
Canada's international engagement
Canada participates actively in global medical device regulatory harmonisation:
- IMDRF — International Medical Device Regulators Forum (Canada is a founding member)
- MDSAP — Medical Device Single Audit Program (Canada, US, Australia, Brazil, Japan)
- ICH — International Council for Harmonisation (for drug-device combination products)
Official source